These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Contrast-Induced Nephropathy: From Pathophysiology to Preventive Strategies. Azzalini L; Spagnoli V; Ly HQ Can J Cardiol; 2016 Feb; 32(2):247-55. PubMed ID: 26277092 [TBL] [Abstract][Full Text] [Related]
3. Frequency and risk factors of contrast-induced nephropathy after cardiac catheterization in type II diabetic patients: a study among Egyptian patients. Sany D; Refaat H; Elshahawy Y; Mohab A; Ezzat H Ren Fail; 2014 Mar; 36(2):191-7. PubMed ID: 24138570 [TBL] [Abstract][Full Text] [Related]
4. Prevention of acute renal failure post-contrast imaging in cardiology: a randomized study. Alessandri N; Lanzi L; Garante CM; Tersigni F; Sergiacomi R; Petrassi M; Di Matteo A; Tufano F Eur Rev Med Pharmacol Sci; 2013 Feb; 17 Suppl 1():13-21. PubMed ID: 23436661 [TBL] [Abstract][Full Text] [Related]
5. Clinically significant contrast induced acute kidney injury after non-emergent cardiac catheterization--risk factors and impact on length of hospital stay. Kashif W; Khawaja A; Yaqub S; Hussain SA J Coll Physicians Surg Pak; 2013 Dec; 23(12):842-7. PubMed ID: 24304985 [TBL] [Abstract][Full Text] [Related]
6. Circulating tumour necrosis factor receptors 1 and 2 predict contrast-induced nephropathy and progressive renal dysfunction: a prospective cohort study. An JN; Yoo KD; Hwang JH; Kim HL; Kim SH; Yang SH; Kim JH; Kim DK; Oh YK; Kim YS; Lim CS; Lee JP Nephrology (Carlton); 2015 Aug; 20(8):552-9. PubMed ID: 25783484 [TBL] [Abstract][Full Text] [Related]
7. Elevated homocysteine and the risk of contrast-induced nephropathy: a cohort study. Barbieri L; Verdoia M; Schaffer A; Niccoli G; Perrone-Filardi P; Bellomo G; Marino P; Suryapranata H; Luca GD Angiology; 2015 Apr; 66(4):333-8. PubMed ID: 24830422 [TBL] [Abstract][Full Text] [Related]
8. Contrast-media induced nephropathy in patients undergoing coronary angiography. Gomes VO; Blaya P; Poli de Figueiredo CE; Manfroi W; Caramori P J Invasive Cardiol; 2003 Jun; 15(6):304-10. PubMed ID: 12777666 [TBL] [Abstract][Full Text] [Related]
14. Impact of high loading dose of atorvastatin in diabetic patients with renal dysfunction undergoing elective percutaneous coronary intervention: a randomized controlled trial. Shehata M; Hamza M Cardiovasc Ther; 2015 Apr; 33(2):35-41. PubMed ID: 25677920 [TBL] [Abstract][Full Text] [Related]
15. Prevention of contrast-induced nephropathy with single bolus erythropoietin in patients with diabetic kidney disease: A randomized controlled trial. Shema-Didi L; Kristal B; Eizenberg S; Marzuq N; Sussan M; Feldman-Idov Y; Ofir P; Atar S Nephrology (Carlton); 2016 Apr; 21(4):295-300. PubMed ID: 26370061 [TBL] [Abstract][Full Text] [Related]
16. A comparison of definitions of contrast-induced nephropathy in patients with normal serum creatinine. Khatami MR; Nikravan N; Salari-Far M; Davoudi S; Pahlavan-Sabbagh MR Saudi J Kidney Dis Transpl; 2016 Jan; 27(1):94-100. PubMed ID: 26787573 [TBL] [Abstract][Full Text] [Related]
17. Subclinical and clinical contrast-induced acute kidney injury: data from a novel blood marker for determining the risk of developing contrast-induced nephropathy (ENCINO), a prospective study. Akrawinthawong K; Ricci J; Cannon L; Dixon S; Kupfer K; Stivers D; Alexander P; David S; McCullough PA Ren Fail; 2015 Mar; 37(2):187-91. PubMed ID: 25519207 [TBL] [Abstract][Full Text] [Related]